Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 471

1.

Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.

Matsuo K, Machida H, Grubbs BH, Matsuzaki S, Klar M, Roman LD, Sood AK, Gershenson DM.

Gynecol Oncol. 2019 Nov 27. pii: S0090-8258(19)31482-9. doi: 10.1016/j.ygyno.2019.08.030. [Epub ahead of print]

PMID:
31954535
2.

Evolving population-based statistics for rare epithelial ovarian cancers.

Matsuo K, Machida H, Matsuzaki S, Grubbs BH, Klar M, Roman LD, Sood AK, Gershenson DM, Wright JD.

Gynecol Oncol. 2019 Dec 18. pii: S0090-8258(19)31781-0. doi: 10.1016/j.ygyno.2019.11.122. [Epub ahead of print]

PMID:
31954534
3.

Effect of Ultra High-Resolution Computed Tomography and Model-Based Iterative Reconstruction on Detectability of Simulated Submillimeter Artery.

Morisaka H, Shimizu Y, Adachi T, Fukushima K, Arai T, Yamamura W, Koyanagi M, Kariyasu T, Machida H, Sano K, Yokoyama K, Ichikawa T.

J Comput Assist Tomogr. 2020 Jan/Feb;44(1):32-36. doi: 10.1097/RCT.0000000000000963.

PMID:
31939879
4.

Clinical importance of cold polypectomy during the insertion phase in the left side of the colon and rectum: a multicenter randomized controlled trial (PRESECT STUDY).

Teramoto A, Aoyama N, Ebisutani C, Matsumoto T, Machida H, Yoshida S, Uchima N, Utsumi T, Tochio T, Hirata D, Iwatate M, Hattori S, Fujita M, Sano W, Sano Y.

Gastrointest Endosc. 2019 Dec 23. pii: S0016-5107(19)32561-1. doi: 10.1016/j.gie.2019.12.019. [Epub ahead of print]

PMID:
31877310
5.

Clinical impact of visceral-to-subcutaneous fat ratio in patients with acute aortic dissection.

Miura Y, Higuchi S, Matsushita K, Kariyasu T, Machida H, Yokoyama K, Soejima K, Satoh T.

PLoS One. 2019 Dec 23;14(12):e0226642. doi: 10.1371/journal.pone.0226642. eCollection 2019.

6.

Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States.

Violette CJ, Mandelbaum RS, Nusbaum DJ, Duval CJ, Matsuzaki S, Machida H, Roman LD, Matsuo K.

Gynecol Oncol Rep. 2019 Oct 24;30:100510. doi: 10.1016/j.gore.2019.100510. eCollection 2019 Nov.

7.

Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia.

Matsuo H, Ishikawa E, Machida H, Mizutani Y, Tanoue A, Ohnishi T, Murata T, Okamoto S, Ogura T, Nishimura Y, Ito H, Yasutomi M, Katayama K, Nomura S, Ito M.

Clin Exp Nephrol. 2019 Dec 16. doi: 10.1007/s10157-019-01829-z. [Epub ahead of print]

PMID:
31845065
8.

E-selectin as a prognostic factor of patients hospitalized due to acute inflammatory respiratory diseases: a single institutional study.

Nakano H, Inoue S, Shibata Y, Abe K, Murano H, Yang S, Machida H, Sato K, Sato C, Nemoto T, Nishiwaki M, Kimura T, Yamauchi K, Sato M, Igarashi A, Tokairin Y, Watanabe M.

EXCLI J. 2019 Nov 11;18:1062-1070. doi: 10.17179/excli2019-1624. eCollection 2019.

9.

Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis.

Machida H, Tokunaga H, Matsuo K, Matsumura N, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Mikami M.

Eur J Surg Oncol. 2019 Dec 4. pii: S0748-7983(19)31469-6. doi: 10.1016/j.ejso.2019.11.520. [Epub ahead of print]

PMID:
31818526
10.

Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate.

Machida H, Iwata T, Okugawa K, Matsuo K, Saito T, Tanaka K, Morishige K, Kobayashi H, Yoshino K, Tokunaga H, Ikeda T, Shozu M, Yaegashi N, Enomoto T, Mikami M.

Gynecol Oncol. 2019 Nov 23. pii: S0090-8258(19)31672-5. doi: 10.1016/j.ygyno.2019.11.021. [Epub ahead of print]

PMID:
31767188
11.

Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy.

Chang EJ, Mandelbaum RS, Nusbaum DJ, Violette CJ, Matsushima K, Klar M, Matsuzaki S, Machida H, Kanao H, Roman LD, Matsuo K.

J Minim Invasive Gynecol. 2019 Nov 16. pii: S1553-4650(19)31291-9. doi: 10.1016/j.jmig.2019.11.004. [Epub ahead of print]

PMID:
31743796
12.

Effect of Iron Deficiency on a Murine Model of Smoke-Induced Emphysema.

Sato K, Inoue S, Igarashi A, Tokairin Y, Yamauchi K, Kimura T, Nishiwaki M, Nemoto T, Nakano H, Sato M, Machida H, Yang S, Minegishi Y, Furuyama K, Watanabe M, Shibata Y.

Am J Respir Cell Mol Biol. 2019 Nov 14. doi: 10.1165/rcmb.2018-0239OC. [Epub ahead of print]

PMID:
31726018
13.

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study.

Matsuo K, Shimada M, Matsuzaki S, Machida H, Nagase Y, Saito T, Kamiura S, Iwata T, Sugiyama T, Mikami M.

J Clin Med. 2019 Nov 1;8(11). pii: E1822. doi: 10.3390/jcm8111822.

14.

Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.

Matsuo K, Nusbaum DJ, Machida H, Huang Y, Khetan V, Matsuzaki S, Klar M, Grubbs BH, Roman LD, Wright JD.

Am J Obstet Gynecol. 2019 Oct 30. pii: S0002-9378(19)31236-0. doi: 10.1016/j.ajog.2019.10.010. [Epub ahead of print]

PMID:
31678092
15.

Treatment and outcome of placenta percreta: Primary cesarean hysterectomy versus conservative management.

Licon E, Matsuzaki S, Opara KN, Machida H, Roman LD, Sasso EB, Matsuo K.

Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:201-203. doi: 10.1016/j.ejogrb.2019.09.017. Epub 2019 Sep 20. No abstract available.

PMID:
31627939
16.

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.

Matsuo K, Machida H, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Enomoto T, Mikami M.

Obstet Gynecol. 2019 Nov;134(5):1017-1026. doi: 10.1097/AOG.0000000000003507.

17.

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study.

Machida H, Matsuo K, Enomoto T, Mikami M.

J Gynecol Oncol. 2019 Nov;30(6):e113. doi: 10.3802/jgo.2019.30.e113. No abstract available.

18.

Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients.

Hen Y, Iguchi N, Kanisawa M, Takada K, Machida H, Takara A, Teraoka K, Takamisawa I, Takayama M, Yoshikawa T.

Heart Vessels. 2019 Sep 3. doi: 10.1007/s00380-019-01496-w. [Epub ahead of print]

PMID:
31482217
19.

Usefulness of imprint cytology of gonadoblastoma with dysgerminoma in a patient with Turner syndrome and a Y chromosome: A case report and literature review.

Nagai T, Hasegawa K, Motegi E, Machida H, Sasaki H, Kato H, Kosaka N, Fukasawa I, Kuroda H.

Diagn Cytopathol. 2019 Nov;47(11):1203-1207. doi: 10.1002/dc.24282. Epub 2019 Jul 23.

PMID:
31336030
20.

Creation of High-Density and Low-Defect Molecular Films with a Flat-on Conformation by Interfacial Organization of Triphosphasumanene Trisulfides.

Shidara Y, Abiko Y, Fukushi K, Kimura Y, Hirayama S, Machida H, Fujimori A.

Langmuir. 2019 Jul 30;35(30):9684-9693. doi: 10.1021/acs.langmuir.9b00598. Epub 2019 Jul 17.

PMID:
31288523
21.

Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.

Matsuo K, Huang Y, Zivanovic O, Shimada M, Machida H, Grubbs BH, Roman LD, Wright JD.

Gynecol Oncol. 2019 Sep;154(3):505-515. doi: 10.1016/j.ygyno.2019.06.021. Epub 2019 Jul 4.

PMID:
31279493
22.

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

Surg Oncol. 2019 Jun;29:25-32. doi: 10.1016/j.suronc.2019.02.002. Epub 2019 Feb 7.

PMID:
31196490
23.

Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis.

Matsuo K, Mandelbaum RS, Machida H, Yoshihara K, Muggia FM, Roman LD, Wright JD.

J Clin Med. 2019 May 20;8(5). pii: E714. doi: 10.3390/jcm8050714.

24.

Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.

Matsuo K, Mandelbaum RS, Machida H, Yoshihara K, Muggia FM, Roman LD, Wright JD.

Gynecol Oncol. 2019 Jul;154(1):169-176. doi: 10.1016/j.ygyno.2019.05.014. Epub 2019 May 23.

PMID:
31130286
25.

A rare case of pulmonary lepidic metastasis in patient with branch-type intraductal papillary mucinous carcinoma of the pancreas.

Sakuma F, Tsuchida K, Minaguchi T, Nagashima K, Izawa N, Jinnai H, Sugaya T, Tominaga K, Goda K, Iijima M, Machida H, Kuroda H, Irisawa A.

Clin J Gastroenterol. 2019 Dec;12(6):621-625. doi: 10.1007/s12328-019-00993-9. Epub 2019 May 23.

PMID:
31123981
26.

Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA): A Potential New Tool for Early Detection of Ovarian Cancer.

Hayashi M, Matsuo K, Tanabe K, Ikeda M, Miyazawa M, Yasaka M, Machida H, Shida M, Imanishi T, Grubbs BH, Hirasawa T, Mikami M.

Cancers (Basel). 2019 Apr 27;11(5). pii: E591. doi: 10.3390/cancers11050591.

27.

Utero-ovarian preservation and overall survival of young women with early-stage borderline ovarian tumors.

Mandelbaum RS, Blake EA, Machida H, Grubbs BH, Roman LD, Matsuo K.

Arch Gynecol Obstet. 2019 Jun;299(6):1651-1658. doi: 10.1007/s00404-019-05121-z. Epub 2019 Mar 28.

PMID:
30923905
28.

Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.

Machida H, Matsuo K, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T, Mikami M.

Gynecol Oncol. 2019 Jun;153(3):589-596. doi: 10.1016/j.ygyno.2019.03.243. Epub 2019 Mar 21.

PMID:
30905436
29.

Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.

Matsuo K, Machida H, Mandelbaum RS, Grubbs BH, Roman LD, Sood AK, Gershenson DM.

Gynecol Oncol. 2019 May;153(2):230-237. doi: 10.1016/j.ygyno.2019.02.003. Epub 2019 Feb 20.

PMID:
30797590
30.

Genetic variants of SMAD2/3/4/7 are associated with susceptibility to ulcerative colitis in a Japanese genetic background.

Yamashita A, Inamine T, Suzuki S, Fukuda S, Unoike M, Kawafuchi Y, Machida H, Isomoto H, Nakao K, Tsukamoto K.

Immunol Lett. 2019 Mar;207:64-72. doi: 10.1016/j.imlet.2019.01.007. Epub 2019 Jan 14.

PMID:
30653987
31.

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.

Machida H, Matsuo K, Furusawa A, Kita T, Kitagawa R, Mikami M.

PLoS One. 2019 Jan 7;14(1):e0210125. doi: 10.1371/journal.pone.0210125. eCollection 2019.

32.

Association between the Critical Shoulder Angle and Rotator Cuff Tears in Japan.

Watanabe A, Ono Q, Nishigami T, Hirooka T, Machida H.

Acta Med Okayama. 2018 Dec;72(6):547-551. doi: 10.18926/AMO/56371.

33.

Smaller erector spinae muscle size is associated with inability to recover activities of daily living after pneumonia treatment.

Minegishi Y, Inoue S, Sato K, Abe K, Murano H, Furuyama K, Yang S, Machida H, Nakano H, Sato M, Nemoto T, Sato C, Nishiwaki M, Kimura T, Yamauchi K, Igarashi A, Tokairin Y, Shibata Y, Watanabe M.

Respir Investig. 2019 Mar;57(2):191-197. doi: 10.1016/j.resinv.2018.11.002. Epub 2018 Dec 11.

PMID:
30552073
34.

Validation of the 2018 FIGO cervical cancer staging system.

Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M.

Gynecol Oncol. 2019 Jan;152(1):87-93. doi: 10.1016/j.ygyno.2018.10.026. Epub 2018 Oct 30.

PMID:
30389105
35.

Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Surg Oncol. 2018 Sep;27(3):433-440. doi: 10.1016/j.suronc.2018.05.017. Epub 2018 May 11.

PMID:
30217299
36.

Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.

Matsuo K, Mandelbaum RS, Machida H, Purushotham S, Grubbs BH, Roman LD, Wright JD.

J Gynecol Oncol. 2018 Nov;29(6):e91. doi: 10.3802/jgo.2018.29.e91.

37.

Clinical utility of CA-125 in the management of uterine carcinosarcoma.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

J Gynecol Oncol. 2018 Nov;29(6):e88. doi: 10.3802/jgo.2018.29.e88. No abstract available.

38.

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States.

Matsuo K, Machida H, Mandelbaum RS, Mikami M, Enomoto T, Roman LD, Wright JD.

J Gynecol Oncol. 2018 Nov;29(6):e85. doi: 10.3802/jgo.2018.29.e85. No abstract available.

39.

Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.

Matsuo K, Machida H, Mandelbaum RS, Ragab OM, Roman LD, Wright JD.

Gynecol Oncol. 2018 Nov;151(2):250-256. doi: 10.1016/j.ygyno.2018.08.035. Epub 2018 Sep 6.

PMID:
30197062
40.
41.

Recurrent Small Cell Carcinoma of the Uterine Cervix Responding to Combined Therapy with Paclitaxel, Cisplatin, and Bevacizumab: A Case Report.

Hirasawa T, Kajiwara H, Machida H, Iida T, Ikeda M, Shida M, Mikami M.

Tokai J Exp Clin Med. 2018 Sep 20;43(3):81-84.

42.

Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy vs hysterectomy.

Machida H, Mandelbaum RS, Mikami M, Enomoto T, Sonoda Y, Grubbs BH, Paulson RJ, Roman LD, Wright JD, Matsuo K.

Am J Obstet Gynecol. 2018 Nov;219(5):461.e1-461.e18. doi: 10.1016/j.ajog.2018.08.020. Epub 2018 Aug 21.

43.

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Surg Oncol. 2018 Nov;25(12):3676-3684. doi: 10.1245/s10434-018-6695-z. Epub 2018 Aug 13.

PMID:
30105438
44.

Elevated Levels of Intelectin-1, a Pathogen-binding Lectin, in the BAL Fluid of Patients with Chronic Eosinophilic Pneumonia and Hypersensitivity Pneumonitis.

Shinohara T, Tsuji S, Okano Y, Machida H, Hatakeyama N, Ogushi F.

Intern Med. 2018 Dec 15;57(24):3507-3514. doi: 10.2169/internalmedicine.0841-18. Epub 2018 Aug 10.

45.

Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.

Matsuo K, Blake EA, Machida H, Mandelbaum RS, Roman LD, Wright JD.

Gynecol Oncol. 2018 Sep;150(3):501-508. doi: 10.1016/j.ygyno.2018.07.016. Epub 2018 Jul 24.

PMID:
30054103
46.

Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.

Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD.

J Gynecol Oncol. 2018 Sep;29(5):e69. doi: 10.3802/jgo.2018.29.e69. Epub 2018 May 4.

47.

Trends and outcomes of women with synchronous endometrial and ovarian cancer.

Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, Wright JD.

Oncotarget. 2018 Jun 19;9(47):28757-28771. doi: 10.18632/oncotarget.25550. eCollection 2018 Jun 19.

48.

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.

Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.

Ann Surg Oncol. 2018 Sep;25(9):2756-2766. doi: 10.1245/s10434-018-6547-x. Epub 2018 Jul 3.

PMID:
29971677
49.

Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.

Mhawech-Fauceglia P, Walia S, Yessaian A, Machida H, Matsuo K, Lawrenson K.

Pathology. 2018 Aug;50(5):499-503. doi: 10.1016/j.pathol.2018.03.004. Epub 2018 Jun 8.

PMID:
29891190
50.

Aeromedical Transport Operations Using Helicopters during the 2016 Kumamoto Earthquake in Japan.

Motomura T, Hirabayashi A, Matsumoto H, Yamauchi N, Nakamura M, Machida H, Fujizuka K, Otsuka N, Satoh T, Anan H, Kondo H, Koido Y.

J Nippon Med Sch. 2018;85(2):124-130. doi: 10.1272/jnms.2018_85-19.

Supplemental Content

Loading ...
Support Center